title: JARID1/KDM5 demethylases as cancer targets?
authors.affiliation: a Breast Cancer Biology , Division of Cancer Studies, King's College London , Guy's Hospital, London , UK.
authors.forename: Joyce
authors.initials: J
authors.lastname: Taylor-Papadimitriou
authors.affiliation: a Breast Cancer Biology , Division of Cancer Studies, King's College London , Guy's Hospital, London , UK.
authors.forename: Joy
authors.initials: J
authors.lastname: Burchell
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D056466:Histone Demethylases / Q000037:antagonists & inhibitors; D006801:Humans; D056484:Jumonji Domain-Containing Histone Demethylases / Q000037:antagonists & inhibitors; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics; D009687:Nuclear Proteins / Q000037:antagonists & inhibitors; D012097:Repressor Proteins / Q000037:antagonists & inhibitors; D056485:Retinoblastoma-Binding Protein 2 / Q000037:antagonists & inhibitors
chemical_list: D000970:Antineoplastic Agents; D009687:Nuclear Proteins; D012097:Repressor Proteins; D056466:Histone Demethylases; D056484:Jumonji Domain-Containing Histone Demethylases; C070050:KDM5A protein, human; C119611:KDM5B protein, human; C086877:KDM5C protein, human; D056485:Retinoblastoma-Binding Protein 2
keywords: H3K4 methylation; Small molecular weight inhibitors; histone demethylases